Discount Code (0% Off) has been applied.
 
Enter a search term.

If you can't find what you were looking for, please contact us using one of the methods below so we can better serve you.

1 (800) 854-7220
answers@mcguff.com Suggest an Item
Categories
RSS

Media

Visit Us at A4M’s LongevityFest 2024 Conference!
Visit Us at A4M’s LongevityFest 2024 Conference!

We will be exhibiting at A4M’s LongevityFest 2024 conference December 13-15, 2024 in Las Vegas. We h...

Manage IV Solution Shortages with Confidence – Try our Osmolarity Calculator Free
Manage IV Solution Shortages with Confidence – Try our Osmolarity Calculator Free

To help support healthcare providers during the IV solution shortage, we’re offering free access to our Osmolarity Calculator until February 1, 2025, which will help easily calculate the right osmolarity when adjusting to new IV solutions. 

Ensuring Continuity: Our Commitment Through the IV Solution Shortage
Ensuring Continuity: Our Commitment Through the IV Solution Shortage

In response to the recent nationwide shortage of IV solutions, triggered by unexpected damages at key manufacturing sites due to Hurricane Helene, we wanted to assure you of our unwavering commitment to your needs during this challenging period.

Historical Highlights of ASCOR® Ascorbic Acid Injection (Vitamin C Injection)
Historical Highlights of ASCOR® Ascorbic Acid Injection (Vitamin C Injection)

Ascorbic Acid Injection (vitamin C) is one of the vital therapies that has been used for decades to address severe vitamin C deficiency and other medical conditions.

McGuff is committed to preserving patient access to Ascorbic Acid Injection. This article outlines the historical highlights of ASCOR, the original FDA-approved Ascorbic Acid Injection, showcasing our steadfast commitment. 

50% Dextrose Injection, USP is Now Back in Stock!
50% Dextrose Injection, USP is Now Back in Stock!

Great news - after three years of being on manufacturer back order, we now have 50% Dextrose Injection, USP available in stock.

McGuff Pharmaceutical, Inc. Achieves FDA Approval of New Facility
McGuff Pharmaceutical, Inc. Achieves FDA Approval of New Facility

New Facility Allows for Greater Capacity of Pharmaceutical Manufacturing in the U.S.

Medical Professionals Advocating for Continued Access to 503A Compounding Pharmacy Drugs at the California Board of Pharmacy’s Subcommittee Regulation Hearing
Medical Professionals Advocating for Continued Access to 503A Compounding Pharmacy Drugs at the California Board of Pharmacy’s Subcommittee Regulation Hearing

On June 18th, the California Board of Pharmacy (CA BOP) held a regulation hearing on compounded drug preparations. McGuff’s management team, along with an estimated attendance of over 100 people, including medical professionals from diverse specialties, attended this three-hour subcommittee meeting. Their goal was to advocate for continued access to sterile compounded drugs from 503A compounding pharmacies.

503B Compounded Drugs Currently in Development at McGuff Outsourcing Solutions (MOS)
503B Compounded Drugs Currently in Development at McGuff Outsourcing Solutions (MOS)

We’ve been transitioning our 503A compounding pharmacy to a 503B outsourcing facility and are developing many compounded drugs for when we launch, as well as investigating others to develop in the future.

Testosterone is Back in Stock
Testosterone is Back in Stock

Good news - we now have three testosterone injection products available in stock!

ASCOR Shipping Conditions
ASCOR Shipping Conditions

We want to assure our customers that we can safely and effectively ship ASCOR® ascorbic acid injection (vitamin C) unrefrigerated, without ice packs in the shipment packaging, in these warm summer months.

If you receive ASCOR vials warm or even hot, please read the following technical details. 

Coronavirus (COVID-19)

Due to the Coronavirus (COVID-19) outbreak worldwide, the global demand for some Personal Protective Equipment (PPE) is exceeding current supply availability.

In addition, the manufacturing of the PPE and many other wound care/infection prevention products have been impacted by the global response to the Coronavirus. While you may see product availability reduction in the near-term, please be assured that we at McGuff Medical are continuing to work diligently to ensure an uninterrupted supply of products and alternative products to you.

Additionally, in order to ensure healthcare providers have access to the PPEs they need, the McGuff Company is temporarily limiting PPEs to healthcare providers.

As always, please feel free to reach out to our McGuff Customer Service team with any questions that you may have.

Click here for updates regarding Coronavirus Pandemic and Your Supplies and a message from our President